These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1970909)

  • 1. [Current status of therapy for gastroduodenal ulcer].
    Aeberhard P; Lichtenhahn P; Villiger P
    Schweiz Med Wochenschr; 1990 Apr; 120(14):467-75. PubMed ID: 1970909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic strategies in performing emergency surgery for gastroduodenal ulcer perforation in 130 patients over 70 years of age.
    Tsugawa K; Koyanagi N; Hashizume M; Tomikawa M; Akahoshi K; Ayukawa K; Wada H; Tanoue K; Sugimachi K
    Hepatogastroenterology; 2001; 48(37):156-62. PubMed ID: 11268955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting mortality and morbidity in patients with peptic ulcer perforation.
    Kocer B; Surmeli S; Solak C; Unal B; Bozkurt B; Yildirim O; Dolapci M; Cengiz O
    J Gastroenterol Hepatol; 2007 Apr; 22(4):565-70. PubMed ID: 17376052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
    Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
    Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of H2-receptor antagonists on the outcome of treatment of perforated duodenal ulcer.
    Macintyre IM; Millar A
    J R Coll Surg Edinb; 1990 Dec; 35(6):348-52. PubMed ID: 1982317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroduodenal ulcer disease: what surgical indications are left?].
    Cuttat JF; Ruchat P; Chapuis G
    Schweiz Med Wochenschr; 1989 May; 119(21):729-30. PubMed ID: 2569232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in ulcer surgery following introduction of H2-blockers].
    Paimela H; Kivilaakso E; Tuompo P; Peräkylä T; Höckerstedt K; Saarlo I
    Nord Med; 1991; 106(6-7):198-201. PubMed ID: 1677178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
    Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
    Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing patterns in perforated peptic ulcer disease.
    Gunshefski L; Flancbaum L; Brolin RE; Frankel A
    Am Surg; 1990 Apr; 56(4):270-4. PubMed ID: 1973032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeons' attitudes to the operative management of duodenal ulcer perforation and haemorrhage.
    Stringer MD; Cameron AE
    Ann R Coll Surg Engl; 1988 Jul; 70(4):220-3. PubMed ID: 2901246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
    Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].
    Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V
    Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents].
    Bartolotta M; Carditello A
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for peptic ulcer disease in children in the post-histamine2-blocker era.
    Edwards MJ; Kollenberg SJ; Brandt ML; Wesson DE; Nuchtern JG; Minifee PK; Cass DL
    J Pediatr Surg; 2005 May; 40(5):850-4. PubMed ID: 15937829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgery of complicated gastroduodenal ulcers: outcome at the millennium].
    Kreissler-Haag D; Schilling MK; Maurer CA
    Zentralbl Chir; 2002 Dec; 127(12):1078-82. PubMed ID: 12529824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment].
    Peitsch W
    Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of H2 antagonists on outcome of simple closure for perforated duodenal ulcer.
    Koh KB; Chang KW
    Singapore Med J; 1992 Oct; 33(5):472-3. PubMed ID: 1360708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trend in emergency surgery for perforated duodenal ulcer.
    Gürleyik E
    J Coll Physicians Surg Pak; 2003 Dec; 13(12):708-10. PubMed ID: 15569558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of antirheumatic drug-induced ulcer in comparison with peptic gastroduodenal ulcer. Five-year analysis of a hospital patient sample].
    Benz J; Wiedbrauck F; Hotz J
    Med Klin (Munich); 1993 Aug; 88(8):463-70. PubMed ID: 8413047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.